Current and Emerging Targeted Therapy in Advanced Gastroesophageal Adenocarcinoma.

Oakley O, Mahmood U, Ahmad Y, Smyth E

Open source

DOI
10.3390/ph19091420
Published
2026 Sep 8
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091420,
  title = {Current and Emerging Targeted Therapy in Advanced Gastroesophageal Adenocarcinoma.},
  author = {Oakley O and Mahmood U and Ahmad Y and Smyth E},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19091420},
  url = {https://doi.org/10.3390/ph19091420}
}

RIS

TY  - JOUR
TI  - Current and Emerging Targeted Therapy in Advanced Gastroesophageal Adenocarcinoma.
AU  - Oakley O
AU  - Mahmood U
AU  - Ahmad Y
AU  - Smyth E
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19091420
UR  - https://doi.org/10.3390/ph19091420
ER  - 

APA

O, O., U, M., Y, A., & E, S. (2026). Current and Emerging Targeted Therapy in Advanced Gastroesophageal Adenocarcinoma.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19091420

Source records